En
Da
Fr
De
Sv
Deal History
Services
Corporate Finance
Debt Advisory
Equity Research
Growth Equity Financing
IPO Strategy & Preparation
Industries
Business Services
Consumer & Internet
Industrial Technology
Life Science
Software & TMT
Energy & Infrastructure
Insights
News
Newsletter
Research
About us
Company
Team
Offices
Globalscope
Career
Events
Contact
En
Da
Fr
De
Sv
Main menu button
Team
Deals
Contact
Equity Research
Team
Deals
Contact
News
All
Abera Bioscience
Adventure Box
Adverty
All for One Group
ALM Equity
Alzecure Pharma
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CellaVision
CSAM Health Group
DanCann Pharma
Ecoclime
Elicera Therapeutics
Frequentis
FRISQ
Future Gaming
GHP Specialty Care
H&D Wireless
Hanza
Herantis Pharma
InCoax
Kancera
Medclair Invest
Midsummer
Modus Therapeutics
Moninvent
NeoDynamics
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Pharmiva
Raytelligence
Risk Intelligence
SBB i Norden
Sensec
Spotlight Group
Svenska Aerogel
Svenska Aerogel
Thinc Jetty
Ytrade Group
Zazz Energy
Zinzino
All
Company News
Corporate Finance
Equity Research
Events
In Media
M&A Know-how
Macro and markets
Market Snapshots
Uncategorized
15 Mar 2022
Analysis update Modus Therapeutics Q4 2021: Advances at a high pace
Equity Research
Modus Therapeutics
06 Dec 2021
Mrkt BUZZ Modus: Executing on an ambitious timeline
Equity Research
Modus Therapeutics
08 Nov 2021
Mrkt BUZZ Modus: Benefiting from sepsis care initiative
Equity Research
Modus Therapeutics
31 Oct 2021
Initial coverage Modus: Promising Phase I candidate in huge market
Equity Research
Modus Therapeutics
07 Jul 2021
Investment case Modus Therapeutics: Significant potential with proven technology
Equity Research
Modus Therapeutics
